Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Gettinger SN"'
Autor:
Kim, Dw, Ahn, Mj, Shi, Yk, De, Tm, Yang, Pc, Riely, Gj, Crino', Lucio, Evans, Tl, Liu, Xq, Han, Jy, Salgia, R, Moro Sibilot, D, Shi, Ou, Gettinger, Sn, Wu, Yl, Lanzalone, S, Polli, A, Iyer, S, Shaw, At
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3982::fe6b90e2e7ada2c4acbc6bb51069da1d
http://hdl.handle.net/11391/1334329
http://hdl.handle.net/11391/1334329
Autor:
Socinski MA, Stinchcombe TE, Moore DT, Gettinger SN, Decker RH, Petty WJ, Blackstock AW, Schwartz G, Lankford S, Khandani A, Morris DE
Publikováno v:
Journal of Clinical Oncology; 11/10/2012, Vol. 30 Issue 32, p3953-3959, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Topalian SL (AUTHOR), Hodi FS (AUTHOR), Brahmer JR (AUTHOR), Gettinger SN (AUTHOR), Smith DC (AUTHOR), McDermott DF (AUTHOR), Powderly JD (AUTHOR), Carvajal RD (AUTHOR), Sosman JA (AUTHOR), Atkins MB (AUTHOR), Leming PD (AUTHOR), Spigel DR (AUTHOR), Antonia SJ (AUTHOR), Horn L (AUTHOR), Drake CG (AUTHOR), Pardoll DM (AUTHOR), Chen L (AUTHOR), Sharfman WH (AUTHOR), Anders RA (AUTHOR), Taube JM (AUTHOR)
Publikováno v:
New England Journal of Medicine. 6/28/2012, Vol. 366 Issue 26, p2443-2454. 12p.
Autor:
Schoenfeld AJ; Division of Solid Tumor Oncology, Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York., Lee SM; Clinical Research Division, Department of Medicine, Fred Hutchinson Cancer Center, Seattle, Washington., Doger de Spéville B; TART Madrid-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Gettinger SN; Division of Medical Oncology, Department of Medicine, Yale Cancer Center, North Haven, Connecticut., Häfliger S; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland., Sukari A; Department of Oncology, Barbara Ann Karmanos Cancer Hospital, Detroit, Michigan., Papa S; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom., Rodríguez-Moreno JF; Department of Medical Oncology, Hospital Universitario HM Sanchinarro, Centro Integral Oncológico Clara Campal, Madrid, Spain., Graf Finckenstein F; Iovance Biotherapeutics, Inc., San Carlos, California., Fiaz R; Iovance Biotherapeutics, Inc., San Carlos, California., Catlett M; Iovance Biotherapeutics, Inc., San Carlos, California., Chen G; Iovance Biotherapeutics, Inc., San Carlos, California., Qi R; Iovance Biotherapeutics, Inc., San Carlos, California., Masteller EL; Iovance Biotherapeutics, Inc., San Carlos, California., Gontcharova V; Iovance Biotherapeutics, Inc., San Carlos, California., He K; Division of Medical Oncology, Department of Internal Medicine, Thoracic Oncology Program, Ohio State University, Columbus, Ohio.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Aug 02; Vol. 14 (8), pp. 1389-1402.
Autor:
Gettinger SN; Yale University, New Haven, CT., Song Z; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Reckamp KL; Cedars Sinai Medical Center, Los Angeles, CA., Moscow JA; Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Gray RJ; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., Wang V; Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA., McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, MD., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD., Hamilton SR; City of Hope National Medical Center, Duarte, CA., Kong XT; UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, CA., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Arteaga CL; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, TX., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA., Chen AP; Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, MA.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2024 Jul; Vol. 8, pp. e2300725.
Autor:
Unger JM; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Qian L; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Redman MW; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Tavernier SS; Idaho State University, Pocatello, ID, USA., Minasian L; Division of Cancer Prevention, National Cancer Institute, Community Oncology and Prevention Trials Group, Rockville, MD, USA., Sigal EV; Friends of Cancer Research, Washington, DC, USA., Papadimitrakopoulou VA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pfizer Oncology, Inc, New York, NY, USA., Leblanc M; SWOG Statistics and Data Management Center, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA., Cleeland CS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dzingle SA; SWOG Data Operations Center, Cancer Research and Biostatistics, Seattle, WA, USA., Summers TJ; Cookeville Regional Medical Center, Southeast NCORP, Cookeville, TN, USA., Chao H; Veterans Affairs Connecticut Healthcare System, Yale University School of Medicine, Massachusetts Veterans Epidemiology Research and Information Center, New Haven, CT, USA., Madhusudhana S; University Health Truman Medical Center, University of Kansas Cancer Center-Midwest Cancer Alliance Rural MU National Cancer Institute Community Oncology Research Program, Kansas City, MO, USA., Villaruz L; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA., Crawford J; Duke Cancer Institute, Durham, NC, USA., Gray JE; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Kelly KL; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Gandara DR; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA., Bazhenova L; University of California San Diego Moores Cancer Center, La Jolla, CA, USA., Herbst RS; Yale Cancer Center, New Haven, CT, USA., Gettinger SN; Yale Cancer Center, New Haven, CT, USA., Moinpour CM; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Apr 11; Vol. 115 (4), pp. 437-446.
Autor:
Lee SM; Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY., Fan W; Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY., Wang A; Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY., Vaidya R; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, WA., Redman MW; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, WA., Gettinger SN; Yale Cancer Center, New Haven, CT., Bazhenova L; University of California San Diego Moores Cancer Center, La Jolla, CA., Herbst RS; Yale Cancer Center, New Haven, CT., Hershman DL; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY., Unger JM; SWOG Statistics and Data Management Center, Fred Hutchinson Cancer Center, Seattle, WA.
Publikováno v:
JCO clinical cancer informatics [JCO Clin Cancer Inform] 2023 Apr; Vol. 7, pp. e2200165.
Autor:
Wu X; Section of Interventional Radiology, Department of Radiology and Biomedical Imaging, University of California, San Francisco, California., Uhlig J; Department of Diagnostic and Interventional Radiology, University Medical Center Göettingen, Göettingen, Germany., Blasberg JD; Section of Thoracic Surgery, Department of Surgery, Yale School of Medicine, New Haven, Connecticut., Gettinger SN; Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut., Suh RD; Department of Radiological Sciences, Ronald Reagan UCLA Medical Center, Los Angeles, California., Solomon SB; Section of Interventional Radiology, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Kim HS; Division of Vascular and Interventional Radiology, Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, Maryland; University of Maryland Marlene and Stewart Greenbaum Comprehensive Cancer Center, Baltimore, Maryland. Electronic address: kevin.kim@umm.edu.
Publikováno v:
Journal of vascular and interventional radiology : JVIR [J Vasc Interv Radiol] 2022 Aug; Vol. 33 (8), pp. 964-971.e2. Date of Electronic Publication: 2022 Apr 28.
Autor:
Gettinger SN; Yale Cancer Center, Yale-New Haven Hospital, New Haven, Connecticut., Huber RM; Thoracic Oncology Centre Munich, University Hospital of Munich, member of the German Center for Lung Research (DZL, CPC-M), Munich, Germany., Kim DW; Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea., Bazhenova L; University of California San Diego Moores Cancer Center, La Jolla, California., Hansen KH; Department of Clinical Oncology, Odense University Hospital, Odense, Denmark., Tiseo M; Department of Medicine and Surgery, University of Parma, Parma, Italy., Langer CJ; University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania., Paz-Ares Rodríguez LG; Medical Oncology Department, Hospital Universitario, Madrid, Spain., West HL; City of Hope Comprehensive Cancer Center, Duarte, California., Reckamp KL; City of Hope Comprehensive Cancer Center, Duarte, California.; Current Affiliation: Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California., Weiss GJ; MiRanostics Consulting, Oro Valley, Arizona., Smit EF; Thoracic Oncology Service, Netherlands Cancer Institute, Amsterdam, The Netherlands., Hochmair MJ; Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Department of Respiratory and Critical Care Medicine, Klinik Floridsdorf, Vienna, Austria., Kim SW; Department of Oncology, Asan Medical Center, Seoul, South Korea., Ahn MJ; Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Kim ES; City of Hope Comprehensive Cancer Center, Duarte, California., Groen HJM; Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands., Pye J; Oncology Statistics, Takeda Development Center Americas, Inc., Lexington, Massachusetts., Liu Y; Oncology Statistics, Takeda Development Center Americas, Inc., Lexington, Massachusetts., Zhang P; Clinical Science, Takeda Development Center Americas, Inc., Lexington, Massachusetts.; Division of Medical Oncology, Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado., Vranceanu F; Oncology Statistics, Takeda Development Center Americas, Inc., Lexington, Massachusetts.; Clinical Science, Takeda Development Center Americas, Inc., Lexington, Massachusetts., Camidge DR; Division of Medical Oncology, Department of Medicine, University of Colorado Cancer Center, Aurora, Colorado.
Publikováno v:
JTO clinical and research reports [JTO Clin Res Rep] 2022 Jul 31; Vol. 3 (9), pp. 100385. Date of Electronic Publication: 2022 Jul 31 (Print Publication: 2022).